Loading clinical trials...
Loading clinical trials...
This study is being conducted to determine how safe and how well tolerated LY3462817 is when given to participants with psoriasis. Blood tests will be done to check how much LY3462817 is in the bloods...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eli Lilly and Company
NCT07474792 · Plaque Psoriasis
NCT06857942 · Psoriasis, Overweight or Obesity
NCT06979453 · Plaque Psoriasis
NCT07471048 · Psoriasis
NCT07449234 · Psoriasis
Dermatology Associates - Los Angeles
Los Angeles, California
Miami Dermatology and Laser Research
Miami, Florida
Advanced Pharma Clinical Research
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions